SUSCEPTIBILITY OF CONGENITALLY IMMUNODEFICIENT MICE TO A NONENCAPSULATED STRAIN OF CRYPTOCOCCUS-NEOFORMANS

被引:13
|
作者
SALKOWSKI, CA [1 ]
BALISH, E [1 ]
机构
[1] UNIV WISCONSIN,SCH MED,DEPT MED MICROBIOL & IMMUNOL,MADISON,WI 53706
关键词
CRYPTOCOCCUS-NEOFORMANS; CAPSULE; IMMUNODEFICIENT MICE;
D O I
10.1139/m91-144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The susceptibility of congenitally immunodeficient mice to a nonencapsulated strain of Cryptococcus neoformans (strain M7) was evaluated. Gnotobiotic mice with defined congenital defects in innate immunity (beige) or cell-mediated immunity (athymic) or with combined defects in innate and cellular immunity (beige athymic) were i.v. challenged with C neoformans M7. The nonencapsulated strain of C neoformans produced a persistant low-grade infection in the brains of all immunodeficient and immunocompetent mice used in this study. Immunocompetent mice (nu/+;bg/+) and immunodeficient bg/bg mice readily cleared nonencapsulated cryptococci from their kidneys, liver, lungs, and spleen. In contrast to nu/+ mice, nu/nu mice had a reduced capacity to clear nonencapsulated cryptococci from their kidneys and liver after i.v. challenge. Both bg/bg-nu/nu and bg/bg-nu/+ mice developed a low-grade infection in their kidneys, liver, lungs, and spleen, which was maintained throughout the 21-day study. Persistent infections were not due to reversion to an encapsulated state. These data indicate that a capsule may not always be necessary for C neoformans to survive, in vivo, in tissues of immunodeficient and immunocompetent mice.
引用
收藏
页码:834 / 839
页数:6
相关论文
共 50 条
  • [41] LOCALIZATION OF MANNOPROTEIN IN CRYPTOCOCCUS-NEOFORMANS
    VARTIVARIAN, SE
    REYES, GH
    JACOBSON, ES
    JAMES, PG
    CHERNIAK, R
    MUMAW, VR
    TINGLER, MJ
    JOURNAL OF BACTERIOLOGY, 1989, 171 (12) : 6850 - 6852
  • [42] CRYPTOCOCCUS-NEOFORMANS OF SAPROPHYTIC ORIGIN
    SWINNEDESGAIN, D
    SABOURAUDIA-JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1975, 13 (NOV): : 303 - 308
  • [43] CHOLANGITIS ASSOCIATED WITH CRYPTOCOCCUS-NEOFORMANS
    BUCUVALAS, JC
    BOVE, KE
    KAUFMAN, RA
    GILCHRIST, MJR
    OLDHAM, KT
    BALISTRERI, WF
    GASTROENTEROLOGY, 1985, 88 (04) : 1055 - 1059
  • [44] MANNOSYL TRANSFER IN CRYPTOCOCCUS-NEOFORMANS
    WHITE, CW
    JACOBSON, ES
    CANADIAN JOURNAL OF MICROBIOLOGY, 1993, 39 (01) : 129 - 133
  • [45] CRYPTOCOCCUS-NEOFORMANS INFECTION AND AIDS
    JUST, G
    HELM, EB
    STILLE, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (37) : 1420 - 1421
  • [46] A MICROBIOLOGICAL STUDY OF CRYPTOCOCCUS-NEOFORMANS
    SCHMIDT, EG
    ALVAREZDECHOUDENS, JA
    MCELVAIN, NF
    BEARDSLEY, J
    TAWAB, SAA
    ARCHIVES OF BIOCHEMISTRY, 1950, 26 (01): : 15 - 24
  • [47] CRYPTOCOCCUS-NEOFORMANS - ECOLOGY AND IMMUNOLOGY
    BACH, A
    FABRICAN.C
    STENDERU.A
    ANTONIE VAN LEEUWENHOEK JOURNAL OF MICROBIOLOGY AND SEROLOGY, 1969, 35 : E35 - &
  • [48] BIOCHEMICAL VARIATION OF CRYPTOCOCCUS-NEOFORMANS
    SCHMEDING, KA
    JONG, SC
    HUGH, R
    MYCOPATHOLOGIA, 1984, 84 (2-3) : 121 - 131
  • [49] GENETIC COMPLEMENTATION IN CRYPTOCOCCUS-NEOFORMANS
    WHELAN, WL
    KWONCHUNG, KJ
    JOURNAL OF BACTERIOLOGY, 1986, 166 (03) : 924 - 929
  • [50] ANTIBODY IMMUNITY AND CRYPTOCOCCUS-NEOFORMANS
    CASADEVALL, A
    CANADIAN JOURNAL OF BOTANY-REVUE CANADIENNE DE BOTANIQUE, 1995, 73 : S1180 - S1186